Skip to content
Inciteful Med
Resources About us Ask a Question

Is Ehlers-Danlos Syndrome a High-Risk Pregnancy?

Published: | Updated:

Yes, Ehlers-Danlos Syndrome (EDS) is generally considered a high-risk pregnancy because of the strain placed on fragile connective tissues. While the exact dangers depend on the specific EDS subtype, common risks include worsened joint hypermobility, rapid labor, and complications with tissue healing.

Key Takeaways

  • • Ehlers-Danlos Syndrome is considered a high-risk pregnancy, requiring care coordinated by a Maternal-Fetal Medicine (MFM) specialist.
  • • Pregnancy hormones like relaxin can severely worsen joint hypermobility and instability for patients with EDS.
  • • EDS patients face unique delivery challenges, including an increased risk of unusually rapid labor, premature birth, and poor wound healing after delivery.
  • • Vascular EDS (vEDS) is the highest-risk subtype and carries extreme risks of uterine rupture or life-threatening hemorrhage, requiring meticulous cardiovascular monitoring.
  • • Local anesthetic resistance is common in EDS, meaning epidurals may fail and backup pain management plans are essential.

Yes, Ehlers-Danlos Syndrome (EDS) is generally considered a high-risk pregnancy. Because EDS affects the body’s connective tissues—which are heavily strained during pregnancy, labor, and delivery—pregnant individuals face an increased risk of complications [1][2]. However, “high risk” is a broad term. For some patients with EDS, a high-risk designation simply means needing extra physical therapy and careful monitoring. For others, pregnancy can be life-threatening. The specific risks and the required medical management depend entirely on your specific EDS subtype [3][4].

How Pregnancy and Postpartum Hormones Affect Your Joints

During a standard pregnancy, the body releases hormones like relaxin and progesterone. These hormones are designed to loosen the pelvic ligaments to make room for a growing baby and prepare the body for childbirth [5].

If you have EDS, your connective tissues are already overly flexible. The surge of relaxin can severely exacerbate existing joint hypermobility and instability [6][7]. This often leads to significant lumbopelvic (lower back and pelvic) pain, increased joint dislocations, and mobility challenges. It is completely normal and acceptable to need mobility aids (like crutches or a wheelchair) or specialized maternity sacroiliac (SI) joint belts to help stabilize your pelvis during the third trimester [5].

Furthermore, these hormonal effects do not disappear the moment you give birth. Because relaxin levels can remain elevated and take time to return to baseline, your joint instability may persist for months into the postpartum period, requiring continued physical therapy support [6][8].

Labor, Delivery, and Pelvic Floor Risks

The inherent tissue fragility in EDS introduces several unique challenges during delivery and recovery:

  • Rapid Labor: Many EDS patients experience precipitate labor (an extremely fast labor and delivery). It is highly recommended to carry a written birth plan or a letter from your doctor explaining this risk, as triage nurses unfamiliar with EDS may otherwise dismiss how fast your labor is progressing [2][3].
  • Preterm Birth: There is a suspected increased risk of delivering prematurely across several EDS subtypes [1][9].
  • Tissue Tearing and Healing: Tissues involved in childbirth are more fragile, which can increase the risk of severe perineal tearing [9][10]. If a cesarean section (C-section) or episiotomy is necessary, EDS patients face a higher risk of wound dehiscence (where the surgical incision separates instead of healing properly) [11][12].
  • Pelvic Organ Prolapse (POP): Because the pelvic floor relies on connective tissue for support, the strain of carrying a baby and pushing during labor increases the risk of pelvic organ prolapse and urinary incontinence [13][14][15].

Understanding the Risks by EDS Subtype

Hypermobile EDS (hEDS)

Pregnancy with hEDS is generally considered safe and manageable, though it requires specialized obstetric care [2][4]. The primary concerns are usually severe joint pain, worsening hypermobility, pelvic floor dysfunction, and a higher chance of preterm birth [1][15]. While highly uncomfortable and physically demanding, hEDS does not typically pose the life-threatening internal organ risks seen in other subtypes [10].

Vascular EDS (vEDS) - The Highest Risk

Vascular EDS carries extremely high maternal morbidity and mortality risks and requires rigorous preconception counseling. [16][17]. Because vEDS compromises the integrity of blood vessels and organs, the physical stress of pregnancy drastically increases the risk of spontaneous uterine rupture, arterial dissections (tearing of major blood vessels), and life-threatening hemorrhage [18][19][20]. Managing a vEDS pregnancy requires a highly specialized medical team, intensive cardiovascular monitoring, and meticulous surgical planning for delivery [21][22].

Classical EDS (cEDS)

Patients with Classical EDS typically face extreme skin and tissue fragility [11]. The main risks revolve around delivery trauma, severe perineal tearing, and significant complications with surgical wound healing [12][3]. Birth plans must carefully weigh the risks of vaginal tearing against the high risk of surgical wound dehiscence from a C-section.

Rare Subtypes (clEDS, spEDS, dEDS)

For ultra-rare forms like Classical-like EDS (clEDS), Spondylodysplastic EDS (spEDS), and Dermatosparaxis EDS (dEDS), systemic tissue fragility is known, but there is very little published medical data on specific pregnancy outcomes [23][24][25]. Patients with these subtypes are managed on a case-by-case basis by multidisciplinary teams, heavily focusing on known muscular, skeletal, and soft-tissue vulnerabilities [26][27].

Genetic Counseling and Your Baby

Because EDS is a genetic condition, you may wonder about passing it to your child. Many types, such as Classical (cEDS) and Vascular (vEDS), follow an autosomal dominant inheritance pattern, meaning there is a 50% chance of passing the gene to the baby [28][29]. The exact genetic cause of hEDS is still unknown, but it is known to run heavily in families [30]. If there is a chance your baby will inherit EDS, your pediatric team should be alerted prior to delivery so they can handle the newborn with extra care regarding potential tissue fragility or “floppy” joints (hypotonia).

Building Your Care Team

If you have any form of EDS and are pregnant or planning to become pregnant, you should be referred to a Maternal-Fetal Medicine (MFM) specialist (a high-risk obstetrician) [31][17].

An MFM specialist will coordinate a multidisciplinary approach to keep you safe [32]. They can help orchestrate:

  • Anesthesia Planning: Discussing pain management options early is critical. EDS patients frequently experience local anesthetic resistance, meaning epidurals and spinal blocks may fail, wear off too quickly, or require much higher doses [33][34]. You and your anesthesiologist must have a backup plan.
  • Pelvic Floor Physical Therapy: Working with a specialized therapist before, during, and after pregnancy to prevent or manage prolapse and incontinence [35][13].
  • Cardiovascular Screening: Crucial for ruling out undisclosed vascular risks before pregnancy begins [36][21].

Frequently Asked Questions

Will my Ehlers-Danlos Syndrome joint pain get worse during pregnancy?
The pregnancy hormone relaxin causes pelvic ligaments to loosen, which can severely worsen existing joint hypermobility and instability in EDS patients. This often leads to increased joint dislocations, lower back pain, and a need for mobility aids during the third trimester.
Are there specific risks for labor and delivery with EDS?
Yes, pregnant individuals with EDS face a higher risk of unusually rapid labor, premature birth, and severe perineal tearing. There is also a greater risk of surgical incisions separating instead of healing properly if a C-section or episiotomy is necessary.
Why might an epidural not work for someone with Ehlers-Danlos Syndrome?
People with EDS frequently experience local anesthetic resistance. This means pain medications like epidurals and spinal blocks may fail entirely, wear off too quickly, or require much higher doses. You should always discuss a backup pain management plan with your anesthesiology team prior to delivery.
What kind of doctor should I see if I am pregnant with EDS?
If you are pregnant and have any form of Ehlers-Danlos Syndrome, you should be referred to a Maternal-Fetal Medicine (MFM) specialist. This high-risk obstetrician will coordinate a specialized care team to monitor your cardiovascular health, plan for anesthesia, and oversee your physical therapy.
Will my baby inherit Ehlers-Danlos Syndrome?
Because EDS is a genetic condition, there is often a 50% chance of passing the condition to your child, depending on your specific subtype. Your pediatric care team should be alerted before delivery so they can handle your newborn with extra care regarding potential tissue fragility or loose joints.

Questions for Your Doctor

  • • What is your protocol if I experience rapid (precipitate) labor, and how can we document this so triage nurses take my symptoms seriously?
  • • Are you and the anesthesiology team familiar with the local anesthetic resistance common in EDS, and what is our backup pain management plan if an epidural fails?
  • • Based on my specific EDS subtype, what cardiovascular or vascular screenings do I need before getting pregnant?
  • • Given my personal history of tissue fragility and wound healing, do you recommend planning for a vaginal delivery or a C-section?
  • • How soon should I begin working with a specialized pelvic floor physical therapist to minimize my risk of pelvic organ prolapse?

Questions for You

  • • What is my exact EDS subtype, and has it been confirmed through genetic testing?
  • • Have I ever experienced 'failed freezing' at the dentist or needed extra numbing medication during a minor procedure?
  • • Is there any history of unexplained vascular issues, aneurysms, or organ ruptures in my extended family that my doctor should know about?
  • • Am I emotionally and practically prepared to use a mobility aid, such as a wheelchair or SI belt, if my joint instability becomes severe later in the pregnancy?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Pregnancy outcome in joint hypermobility syndrome and Ehlers-Danlos syndrome.

    Sundelin HE, Stephansson O, Johansson K, Ludvigsson JF

    Acta obstetricia et gynecologica Scandinavica 2017; (96(1)):114-119 doi:10.1111/aogs.13043.

    PMID: 27743500
  2. 2

    Hypermobile Ehlers-Danlos syndrome and pregnancy.

    Karthikeyan A, Venkat-Raman N

    Obstetric medicine 2018; (11(3)):104-109 doi:10.1177/1753495X18754577.

    PMID: 30214474
  3. 3

    Ehlers-Danlos Syndrome in Pregnancy: A Review.

    Kang J, Hanif M, Mirza E, Jaleel S

    European journal of obstetrics, gynecology, and reproductive biology 2020; (255()):118-123 doi:10.1016/j.ejogrb.2020.10.033.

    PMID: 33113401
  4. 4

    Twin pregnancy with untyped Ehlers-Danlos syndrome requiring prompt genetic testing: A case report.

    Ogawa S, Mariya T, Fujibe Y, et al.

    Case reports in women's health 2022; (33()):e00384 doi:10.1016/j.crwh.2022.e00384.

    PMID: 35079579
  5. 5

    Mechanisms Underlying Lumbopelvic Pain During Pregnancy: A Proposed Model.

    Daneau C, Abboud J, Marchand AA, et al.

    Frontiers in pain research (Lausanne, Switzerland) 2021; (2()):773988 doi:10.3389/fpain.2021.773988.

    PMID: 35295430
  6. 6

    Do Relaxin Levels Impact Hip Injury Incidence in Women? A Scoping Review.

    Parker EA, Meyer AM, Goetz JE, et al.

    Frontiers in endocrinology 2022; (13()):827512 doi:10.3389/fendo.2022.827512.

    PMID: 35185802
  7. 7

    Ankle Laxity Fluctuation and Sex Hormones in Women with/without Recurrent Sprains.

    Fukano M, Takahashi N, Sakurai T

    International journal of sports medicine 2026; doi:10.1055/a-2804-6786.

    PMID: 41638248
  8. 8

    Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry.

    Rais Y, Drabovich AP

    Journal of proteome research 2024; (23(6)):2013-2027 doi:10.1021/acs.jproteome.4c00027.

    PMID: 38739617
  9. 9

    Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes.

    Igharo D, Thiel JC, Rolke R, et al.

    European journal of neurology 2023; (30(3)):719-728 doi:10.1111/ene.15649.

    PMID: 36437696
  10. 10

    Laryngological presentations of Ehlers-Danlos syndrome: case series of nine patients from two London tertiary referral centres.

    Arulanandam S, Hakim AJ, Aziz Q, et al.

    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2017; (42(4)):860-863 doi:10.1111/coa.12708.

    PMID: 27434416
  11. 11

    Appendiceal torsion in Ehlers-Danlos syndrome: A case report of a rare phenomenon in a rare disease.

    Kim S, Baldwin D, Duarte B

    International journal of surgery case reports 2020; (73()):207-209 doi:10.1016/j.ijscr.2020.06.084.

    PMID: 32721881
  12. 12

    Skin fragility and wound management in Ehlers-Danlos syndromes: a report by the International Consortium on Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Skin Working Group.

    Angwin C, Doolan BJ, Hausser I, et al.

    Clinical and experimental dermatology 2024; (49(12)):1496-1503 doi:10.1093/ced/llae201.

    PMID: 38767179
  13. 13

    Urogynaecology and Ehlers-Danlos syndrome.

    Patel M, Khullar V

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):579-585 doi:10.1002/ajmg.c.31959.

    PMID: 34799982
  14. 14

    Urogenital and pelvic complications in the Ehlers-Danlos syndromes and associated hypermobility spectrum disorders: A scoping review.

    Gilliam E, Hoffman JD, Yeh G

    Clinical genetics 2020; (97(1)):168-178 doi:10.1111/cge.13624.

    PMID: 31420870
  15. 15

    Lower urinary tract involvement in Ehlers-Danlos and Joint Hypermobility syndromes: Review of the literature.

    Boileau A, Brierre T, Castel-Lacanal É, et al.

    The French journal of urology 2024; (34(13)):102698 doi:10.1016/j.fjurol.2024.102698.

    PMID: 39033997
  16. 16

    Pediatric Innominate Artery Pseudoaneurysm Rupture in Vascular Ehlers-Danlos Syndrome: A Case Report.

    Vos A, Burns KM

    Clinical practice and cases in emergency medicine 2021; (5(2)):226-229 doi:10.5811/cpcem.2021.3.51787.

    PMID: 34437011
  17. 17

    [Maternal mortality among women with Marfan syndrome or vascular Ehlers-Danlos syndrome in France, 2001-2012].

    Cheulot P, Saucedo M, Bouvier-Colle MH, et al.

    Gynecologie, obstetrique, fertilite & senologie 2019; (47(1)):30-35 doi:10.1016/j.gofs.2018.11.003.

    PMID: 30497941
  18. 18

    Nine Successful Pregnancy Outcomes in a Woman With Vascular Ehlers-Danlos Syndrome: A Case Report and Literature Review.

    Zaman Z, Henry SJ, Birkeland LE, Petty EM

    WMJ : official publication of the State Medical Society of Wisconsin 2022; (121(4)):e71-e74.

    PMID: 36637850
  19. 19

    Prevalence of vascular complications in Ehlers-Danlos syndrome: a systematic review and meta-analysis.

    Awad AA, Yappalparvi A, Khatib MN, et al.

    Orphanet journal of rare diseases 2025; (20(1)):312 doi:10.1186/s13023-025-03854-6.

    PMID: 40542421
  20. 20

    Management of Hemorrhage During Cesarean Delivery in a Patient With Vascular Ehlers-Danlos Syndrome: A Case Report.

    Grant O, Mulligan K, Donnelly J, et al.

    A&A practice 2023; (17(1)):e01655 doi:10.1213/XAA.0000000000001655.

    PMID: 36706158
  21. 21

    A 27-Year-Old Woman With Postpartum Papillary Muscle Rupture.

    Hutt E, Santos-Martins C, Aguilera J, et al.

    JACC. Case reports 2020; (2(14)):2191-2195 doi:10.1016/j.jaccas.2020.09.023.

    PMID: 34317136
  22. 22

    Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome.

    Jeunemaitre X, Mousseaux E, Frank M, et al.

    Circulation 2025; (151(10)):686-695 doi:10.1161/CIRCULATIONAHA.124.072849.

    PMID: 39906986
  23. 23

    The detailed obstetric course of the first Japanese patient with AEBP1-related Ehlers-Danlos syndrome (classical-like EDS, type 2).

    Sanai H, Nakamura Y, Koike Y, et al.

    The journal of obstetrics and gynaecology research 2023; (49(3)):1043-1047 doi:10.1111/jog.15541.

    PMID: 36600409
  24. 24

    Segmental Absence of Intestinal Musculature in a Child with Type IV Ehlers-Danlos Syndrome.

    Zeky N, Short C, Keith B, et al.

    Children (Basel, Switzerland) 2021; (8(8)) doi:10.3390/children8080680.

    PMID: 34438571
  25. 25

    Systemic manifestations of Ehlers-Danlos syndrome.

    Song B, Yeh P, Harrell J

    Proceedings (Baylor University. Medical Center) 2020; (34(1)):49-53 doi:10.1080/08998280.2020.1805714.

    PMID: 33456144
  26. 26

    Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.

    Miyake N, Kosho T, Matsumoto N

    Advances in experimental medicine and biology 2021; (1348()):235-249 doi:10.1007/978-3-030-80614-9_10.

    PMID: 34807422
  27. 27

    Ehlers-Danlos syndromes: state of the art on clinical practice guidelines.

    Sulli A, Talarico R, Scirè CA, et al.

    RMD open 2018; (4(Suppl 1)):e000790 doi:10.1136/rmdopen-2018-000790.

    PMID: 30402275
  28. 28

    Ehlers-danlos Syndrome in Four Generations.

    Singh HB, Saksena HC, Kochar DK, et al.

    Indian journal of dermatology, venereology and leprology 1983; (49(2)):65-67.

    PMID: 28176709
  29. 29

    Gonosomal Mosaicism for a Novel COL5A1 Pathogenic Variant in Classic Ehlers-Danlos Syndrome.

    Micale L, Foiadelli T, Russo F, et al.

    Genes 2021; (12(12)) doi:10.3390/genes12121928.

    PMID: 34946877
  30. 30

    Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.

    Scicluna K, Formosa MM, Farrugia R, Borg I

    Clinical genetics 2022; (101(1)):20-31 doi:10.1111/cge.14026.

    PMID: 34219226
  31. 31

    Obstetrics and gynecology in Ehlers-Danlos syndrome: A brief review and update.

    Blagowidow N

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):593-598 doi:10.1002/ajmg.c.31945.

    PMID: 34773390
  32. 32

    Bowel perforation in type IV vascular Ehlers-Danlos syndrome. A systematic review.

    El Masri H, Loong TH, Meurette G, et al.

    Techniques in coloproctology 2018; (22(5)):333-341 doi:10.1007/s10151-018-1783-4.

    PMID: 29700641
  33. 33

    Anesthetic Management for Ehlers-Danlos Syndrome, Hypermobility Type Complicated by Local Anesthetic Allergy: A Case Report.

    Cesare AE, Rafer LC, Myler CS, Brennan KB

    The American journal of case reports 2019; (20()):39-42 doi:10.12659/AJCR.912799.

    PMID: 30626862
  34. 34

    Local anaesthetic resistance in a patient with Ehlers-Danlos syndrome undergoing caesarean section with continuous spinal anaesthesia.

    Wloch K, Simpson M, Gowrie-Mohan S

    Anaesthesia reports 2020; (8(1)):56-58 doi:10.1002/anr3.12040.

    PMID: 32537613
  35. 35

    Pelvic Organ Prolapse in Ehlers-Danlos Syndrome.

    Nazemi A, Shapiro K, Nagpal S, et al.

    Case reports in urology 2023; (2023()):6863711 doi:10.1155/2023/6863711.

    PMID: 36875296
  36. 36

    Cardiovascular manifestations of type IV Ehlers-Danlos syndrome - A case report.

    Santos TS, Marçal R, Moldovan O, et al.

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2022; (41(5)):425-430 doi:10.1016/j.repc.2019.05.017.

    PMID: 36062644

This page provides educational information about pregnancy risks associated with Ehlers-Danlos Syndrome. It does not replace professional medical advice; always consult your Maternal-Fetal Medicine specialist for guidance specific to your EDS subtype.

Stay up to date

Get notified when new research about Ehlers Danlos Syndrome (EDS) is published.

No spam. Unsubscribe anytime.